Secretory IgA Test

Secretory immunoglobulin A (sIgA) is the dominant antibody found at mucosal surfaces such as the gut, lungs, and saliva. In the intestines, sIgA acts as the body’s first line of immune defense, coating microbes and toxins to prevent them from attaching to or penetrating the gut wall. Measuring fecal sIgA provides a window into the state of mucosal immunity and how well the immune system communicates with the gut microbiota.

How sIgA Works

sIgA is produced by specialized plasma cells located just beneath the intestinal lining. These cells create polymeric IgA molecules, which are then transported across intestinal cells by the polymeric immunoglobulin receptor (pIgR). During this transport, a portion of the receptor, called the secretory component, is attached to IgA, protecting it from digestion and allowing it to function effectively in the gut lumen. The result is a resilient antibody complex capable of neutralizing pathogens, binding microbial antigens, and shaping a balanced microbial ecosystem.

Interpreting sIgA Levels

A healthy level of fecal sIgA reflects robust mucosal immunity and tolerance, your body’s ability to distinguish between harmless commensal bacteria and harmful invaders. Low sIgA levels suggest impaired mucosal defense, which may occur in chronic stress, malnutrition, or conditions like selective IgA deficiency. These individuals are more prone to infections, allergic sensitization, and autoimmune activation due to increased microbial translocation (the movement of bacteria and toxins across the gut barrier). Conversely, very high sIgA levels can indicate an overactive immune response to ongoing inflammation or infection, such as in inflammatory bowel disease (IBD).

Altered sIgA responses have been observed in Crohn’s disease and ulcerative colitis, where the antibody’s coating patterns on bacteria become dysregulated. This imbalance contributes to gut dysbiosis (a disrupted microbial community) and impaired barrier function. Similarly, infants with low fecal sIgA are more likely to develop allergic diseases later in life, especially when maternal stress or depressive symptoms are present.